Rezo Therapeutics
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $78M
Overview
A genetics-driven oncology company discovering novel drug targets using functional genomics.
Oncology
Technology Platform
An integrated platform combining human genetics, functional genomics, and computational biology to identify and validate novel oncology drug targets.
Funding History
1Total raised:$78M
PIPE$78M
Opportunities
Potential to build a valuable pipeline of first-in-class oncology drugs targeting novel, genetically validated pathways.
Risk Factors
Risk that its novel targets may prove undruggable or fail to show clinical efficacy despite strong genetic rationale.
Competitive Landscape
Competes with other genomics-focused oncology companies like Repare Therapeutics and Frontier Medicines.